Clinical study of different prediction models in predicting diabetic nephropathy in patients with type 2 diabetes mellitus

Table 1 Results of univariate analysis of diabetic nephropathy in patients with type 2 diabetes [n (%)/mean ± SD]

Indicators	DN group (n = 74)	Non-DN group (n = 136)	t/χ²	P value
Age	56.01 ± 9.41	57.42 ± 8.15	-1.129	0.260
Sex			1.150	0.284
Male	27 (36.49)	60 (44.12)
Female	47 (63.51)	76 (55.88)
BMI (kg/m2)	24.60 ± 3.92	23.73 ± 2.94	1.673	0.097
Duration of diabetes (yr)	5.28 ± 1.34	4.86 ± 0.76	2.507	0.014
History of hypertension			0.465	0.495
Yes	24 (32.43)	38 (27.94)
No	50 (67.57)	98 (72.06)
DR			8.761	0.003
Yes	34 (45.95)	24 (17.65)
No	40 (54.05)	112 (82.35)
Coronary heart disease			0.350	0.554
Yes	19 (25.68)	30 (22.06)
No	55 (74.32)	106 (77.94)
FBG (mmol/L)	8.18 ± 1.67	7.71 ± 1.14	2.160	0.033
Scr (μmol/L)	91.25 ± 14.72	84.61 ± 9.80	3.485	0.001
HbAlc (%)	7.04 ± 1.33	6.29 ± 1.05	4.239	< 0.001
BUN (mmol/L)	7.10 ± 0.96	6.78 ± 1.13	2.111	0.036
TC (mmol/L)	4.81 ± 0.89	4.83 ± 0.97	–0.189	0.851
TG (mmol/L)	1.78 ± 0.4	1.72 ± 0.38	1.090	0.277
HDL-C (mmol/L)	1.41 ± 0.31	1.45 ± 0.32	−0.972	0.332
LDL-C (mmol/L)	3.31 ± 0.57	3.33 ± 0.86	−0.185	0.853

BMI: Body mass index; FBG: Fasting blood glucose; Scr: Serum creatinine; HbAlc: Glycosylated hemoglobin; BUN: Blood urea nitrogen; DR: Diabetic retinopathy; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol.